IVD Logix LLC

primary focus is on in vitro diagnostics. Although no longer involved in the day-to-day management of Market Diagnostics International (MDxI), the company I co-founded in 2006, I maintain an ownership interest with exclusive access to MDxI’s IVD Insights™ and IVD LabFile™ databases to serve the needs of our IVD Logix clients." Background

Prior to starting IVD Logix, Larry co-founded Market Diagnostics International (MDxI), where he was instrumental in developing the IVD Insights and IVD LabFile syndicated databases on in vitro diagnostic testing. These complementary databases merged College of American Pathologists' (CAP) Proficiency Testing Program (PT) data with LabFile site demographics to deliver comprehensive IVD tracking and segmentation reports for the US market that covered more than 550 analytes across 10 laboratory testing disciplines. Larry also consulted with MDxI clients in the design and implementation of proprietary international market research studies, coordinated with MDxI’s analytical staff to develop key findings/recommendations, and helped clients integrate these findings into their organizational goals and objectives. Prior to MDxI, he was a senior consultant and co-founder at CaseBauer & Associates, an international business development and research firm exclusively focused on in vitro diagnostics. He has held senior research positions with Becton Dickinson and Company, AdvaMed, Luning Prak Associates, and IQVIA (formerly Quintiles and IMS Health). He is the most recent Past President of the Diagnostics Marketing Association and currently serves on the editorial advisory board of Clinical Omics and the programming advisory board of the Cambridge Healthtech Institute.